Nicolette Sherman
Voorzitter bij Deirdres House
Vermogen: 397 035 $ op 30-04-2024
Actieve functies van Nicolette Sherman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Deirdres House | Voorzitter | - | - |
Loopbaan van Nicolette Sherman
Eerdere bekende functies van Nicolette Sherman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CERTARA, INC. | Human Resources Officer | 13-07-2021 | 21-05-2024 |
| OYSR POIN | Human Resources Officer | 01-04-2020 | 01-07-2021 |
| Sanofi Corp. | Corporate Officer/Principal | 01-06-2008 | 01-04-2020 |
Opleiding van Nicolette Sherman
| Rutgers State University of New Jersey | Graduate Degree |
| University of Delaware | Graduate Degree |
| Lehigh University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Frankrijk | 2 |
Operationeel
| Human Resources Officer | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Bedrijven in privébezit | 3 |
|---|---|
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Sanofi Corp. | |
| Deirdres House |
- Beurs
- Insiders
- Nicolette Sherman
- Ervaring
